Patent · US Active

Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptide

US9678078B2 · kind B2 · utility

1Cited by
0References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 28, 2014
Grant dateJun 13, 2017
Priority date
Expiry dateOct 28, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/58
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods, devices, reagent, systems and kits for the detection, diagnosis of ovarian cancer as well as for the monitoring of ovarian cancer progression and for monitoring the progress of ovarian cancer treatments using BNP as a biomarker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.